Biomarker-Driven Lung Cancer

>

Latest News

Optimizing Biomarker Testing in Early-Stage Disease for Patients With NSCLC
Optimizing Biomarker Testing in Early-Stage Disease for Patients With NSCLC

April 5th 2024

Recommendations for non–small cell lung cancer biomarker testing in early-stage disease were discussed in a presentation regarding metastatic lung cancer by Christine M. Lovly, MD, PhD.

KRYSTAL-12 Study of Adagrasib Meets Primary End Point in KRAS G12C NSCLC
KRYSTAL-12 Study of Adagrasib Meets Primary End Point in KRAS G12C NSCLC

March 29th 2024

Selection of First-Line NSCLC Therapy Influenced by Delayed Testing
Selection of First-Line NSCLC Therapy Influenced by Delayed Testing

March 8th 2024

Comprehensive Molecular Testing Needed for Frontline NSCLC Treatment
Comprehensive Molecular Testing Needed for Frontline NSCLC Treatment

February 19th 2024